Amir T. Fathi, MD, reviews patient cases and the most recent clinical data to provide guidance on optimizing care for acute lymphoblastic leukemia using newer immunotherapy approaches.
Here’s my take on important considerations for ALL diagnosis and initial workup that inform treatment decisions.
Gain expert clinical insights from Jae H. Park, MD, on the anticipation, preparation, and management of toxicities associated with immunotherapies used for patients with ALL.
How do you manage patients with ALL in the era of immunotherapy? In this commentary, Eunice S. Wang, MD, discusses a novel approach of combining chemotherapy with immunotherapy to treat patients with ALL.
Are you interested in seeing treatment recommendations for adult patients with B-cell ALL from 5 experts? In this commentary, Jae H. Park, MD, describes an online Interactive Decision Support Tool that provides expert guidance to clinicians on treatment options for adult patients with B-cell ALL.
Download these slides to review expert insights on optimizing treatment for patients with ALL.
Use this Interactive Decision Support Tool to compare your choice of therapy for patients with ALL with those of 5 renowned experts.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.